KRT17 and cancer: Altogether, 11 studies (19.0%) investigated the clinical relevance of K17 in cancers with a known etiologic association to HPV; of those, 8 (13.8%) were focused on head and neck squamous cell carcinoma (HNSCC) and 3 (5.1%) on cervical squamous cell carcinoma (SCC).